Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations
Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and patholo...
Gespeichert in:
Veröffentlicht in: | Movement disorders 2009-01, Vol.24 (1), p.32-39 |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 39 |
---|---|
container_issue | 1 |
container_start_page | 32 |
container_title | Movement disorders |
container_volume | 24 |
creator | Covy, Jason P. Yuan, Wuxing Waxman, Elisa A. Hurtig, Howard I. Van Deerlin, Vivianna M. Giasson, Benoit I. |
description | Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and pathological features of PD. A novel L1165P mutation was identified in a second patient. This patient had the classical and pathological features of PD, but additionally developed severe neuropsychological symptoms and dementia associated with abundant neurofibrillary tangles in the hippocampal formation; features consistent with a secondary diagnosis of tangle‐predominant dementia. α‐Synuclein‐containing pathological inclusions in these patients also were highly phosphorylated at Ser‐129, similar to other patients with idiopathic PD. These two PD patients also were characterized by the presence of occasional cytoplasmic TDP‐43 inclusions in the temporal cortex, a finding that was not observed in three other patients with the G2019S mutation in LRRK2. These findings extend the clinical and pathological features that may be associated with LRRK2 mutations. © 2008 Movement Disorder Society |
doi_str_mv | 10.1002/mds.22096 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2634827</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66875278</sourcerecordid><originalsourceid>FETCH-LOGICAL-c5126-e1843edf46085b96d089bc787c6e92789e9618be413e69a2733841b56b4f71b63</originalsourceid><addsrcrecordid>eNqFkU1v1DAQhi0EosvCgT-AcgGJQ1qPHX_kglQtUJAWECrQo-U4k8Y0H4udUPrv8XaXBQ6I00gzz8w80kvIY6DHQCk76et4zBgt5R2yAMEh10you2RBtRY5By2OyIMYv1IKIEDeJ0dQUipTf0HsqvODd7bL7FBnGzu1Yzde3jZca4N1EwYfJ-9iNjbbucdhitm1n9psjbPzA-bBuzYLuEE7ZVd-sBFzlvXzlOBxiA_JvcZ2ER_t65J8fv3q0-pNvv5w9nZ1us6dACZzBF1wrJtCUi2qUtZUl5VTWjmJJVO6xDIZV1gAR1lapjjXBVRCVkWjoJJ8SV7s7m7mqsfaJc9gO7MJvrfhxozWm78ng2_N5fjdMMkLne4tybP9gTB-mzFOpvfRYdfZAcc5Gim1EsnkvyAD4EmTJvD5DnRhjDFgc7ABarbJmZScuU0usU_-1P9N7qNKwNM9YGOKpwl2cD4eOAa05CC2dic77tp3ePPvj-bdy_Nfr_PdRgoafxw2bLgyUnElzMX7M6OKj6C-nF8Yyn8C2Oq_sA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>21134130</pqid></control><display><type>article</type><title>Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Covy, Jason P. ; Yuan, Wuxing ; Waxman, Elisa A. ; Hurtig, Howard I. ; Van Deerlin, Vivianna M. ; Giasson, Benoit I.</creator><creatorcontrib>Covy, Jason P. ; Yuan, Wuxing ; Waxman, Elisa A. ; Hurtig, Howard I. ; Van Deerlin, Vivianna M. ; Giasson, Benoit I.</creatorcontrib><description>Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and pathological features of PD. A novel L1165P mutation was identified in a second patient. This patient had the classical and pathological features of PD, but additionally developed severe neuropsychological symptoms and dementia associated with abundant neurofibrillary tangles in the hippocampal formation; features consistent with a secondary diagnosis of tangle‐predominant dementia. α‐Synuclein‐containing pathological inclusions in these patients also were highly phosphorylated at Ser‐129, similar to other patients with idiopathic PD. These two PD patients also were characterized by the presence of occasional cytoplasmic TDP‐43 inclusions in the temporal cortex, a finding that was not observed in three other patients with the G2019S mutation in LRRK2. These findings extend the clinical and pathological features that may be associated with LRRK2 mutations. © 2008 Movement Disorder Society</description><identifier>ISSN: 0885-3185</identifier><identifier>EISSN: 1531-8257</identifier><identifier>DOI: 10.1002/mds.22096</identifier><identifier>PMID: 19006185</identifier><language>eng</language><publisher>Hoboken: Wiley Subscription Services, Inc., A Wiley Company</publisher><subject>Aged ; alpha-Synuclein - analysis ; Amino Acid Sequence ; Biological and medical sciences ; Cohort Studies ; DNA Mutational Analysis ; Female ; Genes, Dominant ; Genetics ; Hippocampus - pathology ; Humans ; Inclusion Bodies - chemistry ; Leucine-rich repeat kinase-2 (LRRK2) ; Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 ; Male ; Medical sciences ; Middle Aged ; Molecular Sequence Data ; Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis ; Mutation, Missense ; Neurofibrillary Tangles ; Neurology ; Parkinson Disease - genetics ; Parkinson Disease - pathology ; Parkinson Disease - psychology ; Parkinson's disease with dementia ; Parkinson's disease/Parkinsonism ; Parkinsonian Disorders - genetics ; Parkinsonian Disorders - pathology ; Parkinsonian Disorders - psychology ; Phosphorylation ; Phosphoserine - analysis ; Point Mutation ; Protein Processing, Post-Translational ; Protein-Serine-Threonine Kinases - chemistry ; Protein-Serine-Threonine Kinases - genetics ; Protein-Serine-Threonine Kinases - physiology ; Sequence Alignment ; Sequence Homology, Amino Acid ; Temporal Lobe - pathology</subject><ispartof>Movement disorders, 2009-01, Vol.24 (1), p.32-39</ispartof><rights>Copyright © 2008 Movement Disorder Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c5126-e1843edf46085b96d089bc787c6e92789e9618be413e69a2733841b56b4f71b63</citedby><cites>FETCH-LOGICAL-c5126-e1843edf46085b96d089bc787c6e92789e9618be413e69a2733841b56b4f71b63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fmds.22096$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fmds.22096$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>230,314,776,780,881,1411,27901,27902,45550,45551</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=21093158$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19006185$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Covy, Jason P.</creatorcontrib><creatorcontrib>Yuan, Wuxing</creatorcontrib><creatorcontrib>Waxman, Elisa A.</creatorcontrib><creatorcontrib>Hurtig, Howard I.</creatorcontrib><creatorcontrib>Van Deerlin, Vivianna M.</creatorcontrib><creatorcontrib>Giasson, Benoit I.</creatorcontrib><title>Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations</title><title>Movement disorders</title><addtitle>Mov. Disord</addtitle><description>Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and pathological features of PD. A novel L1165P mutation was identified in a second patient. This patient had the classical and pathological features of PD, but additionally developed severe neuropsychological symptoms and dementia associated with abundant neurofibrillary tangles in the hippocampal formation; features consistent with a secondary diagnosis of tangle‐predominant dementia. α‐Synuclein‐containing pathological inclusions in these patients also were highly phosphorylated at Ser‐129, similar to other patients with idiopathic PD. These two PD patients also were characterized by the presence of occasional cytoplasmic TDP‐43 inclusions in the temporal cortex, a finding that was not observed in three other patients with the G2019S mutation in LRRK2. These findings extend the clinical and pathological features that may be associated with LRRK2 mutations. © 2008 Movement Disorder Society</description><subject>Aged</subject><subject>alpha-Synuclein - analysis</subject><subject>Amino Acid Sequence</subject><subject>Biological and medical sciences</subject><subject>Cohort Studies</subject><subject>DNA Mutational Analysis</subject><subject>Female</subject><subject>Genes, Dominant</subject><subject>Genetics</subject><subject>Hippocampus - pathology</subject><subject>Humans</subject><subject>Inclusion Bodies - chemistry</subject><subject>Leucine-rich repeat kinase-2 (LRRK2)</subject><subject>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Middle Aged</subject><subject>Molecular Sequence Data</subject><subject>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</subject><subject>Mutation, Missense</subject><subject>Neurofibrillary Tangles</subject><subject>Neurology</subject><subject>Parkinson Disease - genetics</subject><subject>Parkinson Disease - pathology</subject><subject>Parkinson Disease - psychology</subject><subject>Parkinson's disease with dementia</subject><subject>Parkinson's disease/Parkinsonism</subject><subject>Parkinsonian Disorders - genetics</subject><subject>Parkinsonian Disorders - pathology</subject><subject>Parkinsonian Disorders - psychology</subject><subject>Phosphorylation</subject><subject>Phosphoserine - analysis</subject><subject>Point Mutation</subject><subject>Protein Processing, Post-Translational</subject><subject>Protein-Serine-Threonine Kinases - chemistry</subject><subject>Protein-Serine-Threonine Kinases - genetics</subject><subject>Protein-Serine-Threonine Kinases - physiology</subject><subject>Sequence Alignment</subject><subject>Sequence Homology, Amino Acid</subject><subject>Temporal Lobe - pathology</subject><issn>0885-3185</issn><issn>1531-8257</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkU1v1DAQhi0EosvCgT-AcgGJQ1qPHX_kglQtUJAWECrQo-U4k8Y0H4udUPrv8XaXBQ6I00gzz8w80kvIY6DHQCk76et4zBgt5R2yAMEh10you2RBtRY5By2OyIMYv1IKIEDeJ0dQUipTf0HsqvODd7bL7FBnGzu1Yzde3jZca4N1EwYfJ-9iNjbbucdhitm1n9psjbPzA-bBuzYLuEE7ZVd-sBFzlvXzlOBxiA_JvcZ2ER_t65J8fv3q0-pNvv5w9nZ1us6dACZzBF1wrJtCUi2qUtZUl5VTWjmJJVO6xDIZV1gAR1lapjjXBVRCVkWjoJJ8SV7s7m7mqsfaJc9gO7MJvrfhxozWm78ng2_N5fjdMMkLne4tybP9gTB-mzFOpvfRYdfZAcc5Gim1EsnkvyAD4EmTJvD5DnRhjDFgc7ABarbJmZScuU0usU_-1P9N7qNKwNM9YGOKpwl2cD4eOAa05CC2dic77tp3ePPvj-bdy_Nfr_PdRgoafxw2bLgyUnElzMX7M6OKj6C-nF8Yyn8C2Oq_sA</recordid><startdate>20090115</startdate><enddate>20090115</enddate><creator>Covy, Jason P.</creator><creator>Yuan, Wuxing</creator><creator>Waxman, Elisa A.</creator><creator>Hurtig, Howard I.</creator><creator>Van Deerlin, Vivianna M.</creator><creator>Giasson, Benoit I.</creator><general>Wiley Subscription Services, Inc., A Wiley Company</general><general>Wiley</general><scope>BSCLL</scope><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TK</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20090115</creationdate><title>Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations</title><author>Covy, Jason P. ; Yuan, Wuxing ; Waxman, Elisa A. ; Hurtig, Howard I. ; Van Deerlin, Vivianna M. ; Giasson, Benoit I.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c5126-e1843edf46085b96d089bc787c6e92789e9618be413e69a2733841b56b4f71b63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Aged</topic><topic>alpha-Synuclein - analysis</topic><topic>Amino Acid Sequence</topic><topic>Biological and medical sciences</topic><topic>Cohort Studies</topic><topic>DNA Mutational Analysis</topic><topic>Female</topic><topic>Genes, Dominant</topic><topic>Genetics</topic><topic>Hippocampus - pathology</topic><topic>Humans</topic><topic>Inclusion Bodies - chemistry</topic><topic>Leucine-rich repeat kinase-2 (LRRK2)</topic><topic>Leucine-Rich Repeat Serine-Threonine Protein Kinase-2</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Middle Aged</topic><topic>Molecular Sequence Data</topic><topic>Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis</topic><topic>Mutation, Missense</topic><topic>Neurofibrillary Tangles</topic><topic>Neurology</topic><topic>Parkinson Disease - genetics</topic><topic>Parkinson Disease - pathology</topic><topic>Parkinson Disease - psychology</topic><topic>Parkinson's disease with dementia</topic><topic>Parkinson's disease/Parkinsonism</topic><topic>Parkinsonian Disorders - genetics</topic><topic>Parkinsonian Disorders - pathology</topic><topic>Parkinsonian Disorders - psychology</topic><topic>Phosphorylation</topic><topic>Phosphoserine - analysis</topic><topic>Point Mutation</topic><topic>Protein Processing, Post-Translational</topic><topic>Protein-Serine-Threonine Kinases - chemistry</topic><topic>Protein-Serine-Threonine Kinases - genetics</topic><topic>Protein-Serine-Threonine Kinases - physiology</topic><topic>Sequence Alignment</topic><topic>Sequence Homology, Amino Acid</topic><topic>Temporal Lobe - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Covy, Jason P.</creatorcontrib><creatorcontrib>Yuan, Wuxing</creatorcontrib><creatorcontrib>Waxman, Elisa A.</creatorcontrib><creatorcontrib>Hurtig, Howard I.</creatorcontrib><creatorcontrib>Van Deerlin, Vivianna M.</creatorcontrib><creatorcontrib>Giasson, Benoit I.</creatorcontrib><collection>Istex</collection><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Neurosciences Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Movement disorders</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Covy, Jason P.</au><au>Yuan, Wuxing</au><au>Waxman, Elisa A.</au><au>Hurtig, Howard I.</au><au>Van Deerlin, Vivianna M.</au><au>Giasson, Benoit I.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations</atitle><jtitle>Movement disorders</jtitle><addtitle>Mov. Disord</addtitle><date>2009-01-15</date><risdate>2009</risdate><volume>24</volume><issue>1</issue><spage>32</spage><epage>39</epage><pages>32-39</pages><issn>0885-3185</issn><eissn>1531-8257</eissn><abstract>Mutations in LRRK2 are the single most common known cause of Parkinson's disease (PD). Two new PD patients with LRRK2 mutation were identified from a cohort with extensive postmortem assessment. One of these patients harbors the R793M mutation and presented with the typical clinical and pathological features of PD. A novel L1165P mutation was identified in a second patient. This patient had the classical and pathological features of PD, but additionally developed severe neuropsychological symptoms and dementia associated with abundant neurofibrillary tangles in the hippocampal formation; features consistent with a secondary diagnosis of tangle‐predominant dementia. α‐Synuclein‐containing pathological inclusions in these patients also were highly phosphorylated at Ser‐129, similar to other patients with idiopathic PD. These two PD patients also were characterized by the presence of occasional cytoplasmic TDP‐43 inclusions in the temporal cortex, a finding that was not observed in three other patients with the G2019S mutation in LRRK2. These findings extend the clinical and pathological features that may be associated with LRRK2 mutations. © 2008 Movement Disorder Society</abstract><cop>Hoboken</cop><pub>Wiley Subscription Services, Inc., A Wiley Company</pub><pmid>19006185</pmid><doi>10.1002/mds.22096</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0885-3185 |
ispartof | Movement disorders, 2009-01, Vol.24 (1), p.32-39 |
issn | 0885-3185 1531-8257 |
language | eng |
recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_2634827 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete |
subjects | Aged alpha-Synuclein - analysis Amino Acid Sequence Biological and medical sciences Cohort Studies DNA Mutational Analysis Female Genes, Dominant Genetics Hippocampus - pathology Humans Inclusion Bodies - chemistry Leucine-rich repeat kinase-2 (LRRK2) Leucine-Rich Repeat Serine-Threonine Protein Kinase-2 Male Medical sciences Middle Aged Molecular Sequence Data Multiple sclerosis and variants. Guillain barré syndrome and other inflammatory polyneuropathies. Leukoencephalitis Mutation, Missense Neurofibrillary Tangles Neurology Parkinson Disease - genetics Parkinson Disease - pathology Parkinson Disease - psychology Parkinson's disease with dementia Parkinson's disease/Parkinsonism Parkinsonian Disorders - genetics Parkinsonian Disorders - pathology Parkinsonian Disorders - psychology Phosphorylation Phosphoserine - analysis Point Mutation Protein Processing, Post-Translational Protein-Serine-Threonine Kinases - chemistry Protein-Serine-Threonine Kinases - genetics Protein-Serine-Threonine Kinases - physiology Sequence Alignment Sequence Homology, Amino Acid Temporal Lobe - pathology |
title | Clinical and pathological characteristics of patients with Leucine-rich repeat kinase-2 mutations |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T07%3A12%3A31IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Clinical%20and%20pathological%20characteristics%20of%20patients%20with%20Leucine-rich%20repeat%20kinase-2%20mutations&rft.jtitle=Movement%20disorders&rft.au=Covy,%20Jason%20P.&rft.date=2009-01-15&rft.volume=24&rft.issue=1&rft.spage=32&rft.epage=39&rft.pages=32-39&rft.issn=0885-3185&rft.eissn=1531-8257&rft_id=info:doi/10.1002/mds.22096&rft_dat=%3Cproquest_pubme%3E66875278%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=21134130&rft_id=info:pmid/19006185&rfr_iscdi=true |